Are you looking to stay current with all of the latest Pulmonology news articles and research? Look no further! MDLinx Pulmonology medical editors extensively research respiratory medical journals to find the most beneficial Pulmonology clinical literature. Topics range from: Pediatric Pulmonology, Sleep Disorders, Asthma, COPD, Cystic Fibrosis and much more. In a matter of minutes, Pulmonologists and their staff can stay up to date with the most current published information.
On this page, you'll also find MDLinx exclusive content, including monthly highlights from our physician editor, D. Scott Cunningham, MD, PhD. We also feature clinical pearls from our Internal Medicine Physician Review. You can also get the latest updates on salary information, search available Pulmonology jobs, view upcoming Pulmonology and CME conferences and earn some extra cash by participating in Market Research opportunities.
Not yet an MDLinx.com Member??? Sign up now to gain access to MDLinx exclusive content, email alerts that keep you current on the latest medical news, research, and clinical articles on the topics of your choice, special communications and offers from MDLinx and our sponsors. Plus, you can now post your CV to the MDLinx Career Center to be viewed top medical recruiters who will help you find your next dream job.
Your Unread Messages in Pulmonology
See All >> Messages include industry-sponsored communications and special communications from MDLinx
Jill Baker
MDLinx Career Center
NPs and PAs play crucial role amid PCP shortage
Smartest Doc Challenge
MDLinx
Lung Cancer Clinical Pearls
MDLinx Reminder
MDLinx
Conference Center Upgraded with New Tools
MDLinx Top Read
MDLinx
Running from that pile of unread journals?
D Scott Cunningham MD, PhD
Site Editor, MDLinx
ASA reduces risk of ACS in hospitalized pneumonia patients
461 The destructive combination of Scediosporium apiosperum lung disease and exuberant inflammation in cystic fibrosis Paediatric Respiratory Reviews, March 28, 2013
462 Effect of Azithromycin Maintenance Treatment on Infectious Exacerbations Among Patients With Non–Cystic Fibrosis Bronchiectasis: The BAT Randomized Controlled Trial JAMA, March 27, 2013 Evidence Based Medicine Clinical Article
463 Diagnosis of pulmonary tuberculosis Current Opinion in Pulmonary Medicine, March 27, 2013 Review Article
464 Frequency, diagnosis and management of fungal respiratory infections Current Opinion in Pulmonary Medicine, March 27, 2013 Review Article
465 Treatment of pulmonary tuberculosis Current Opinion in Pulmonary Medicine, March 27, 2013 Review Article
466 Respiratory tract infections in the immunocompromised Current Opinion in Pulmonary Medicine, March 27, 2013 Review Article
467 Respiratory infections in HIV-infected adults: epidemiology, clinical features, diagnosis and treatment Current Opinion in Pulmonary Medicine, March 27, 2013 Review Article
468 Advances in nanotechnology for diagnosis and treatment of tuberculosis Current Opinion in Pulmonary Medicine, March 27, 2013 Review Article
469 Pertussis re-emergence in the post-vaccination era Full Text BMC Infectious Diseases, March 27, 2013 Clinical Guideline Clinical Article
470 Sex, Smoking, and Socio-Economic Status Are Associated with Body Composition among Tuberculosis Patients in a Deuterium Dilution Cross-Sectional Study in Mwanza, Tanzania The Journal of Nutrition, March 27, 2013 Clinical Article
471 Role of imaging in the diagnosis and management of parasitic infections Current Opinion in Pulmonary Medicine, March 27, 2013 Review Article
472 Respiratory tract infections during the annual Hajj: potential risks and mitigation strategies Current Opinion in Pulmonary Medicine, March 27, 2013 Review Article
473 Reference ranges and cutoff levels of pneumococcal antibody global serum assays (IgG and IgG2) and specific antibodies in healthy children and adults Medical Microbiology and Immunology, March 27, 2013 Clinical Article
474 Timeliness of 2009 H1N1 vaccine coverage in a low-income pediatric and adolescent population Vaccine , March 27, 2013 Review Article
475 Memory B cell compartment constitution and susceptibility to recurrent lower respiratory tract infections in young children Journal of Leukocyte Biology, March 27, 2013 Review Article
476 Lower artemether, dihydroartemisinin and lumefantrine concentrations during rifampicin-based tuberculosis treatment AIDS, March 27, 2013 Clinical Article
477 Clarithromycin increases linezolid exposure in multidrug-resistant tuberculosis patients European Respiratory Journal , March 26, 2013 Clinical Article
478 Non-Invasive Biomarkers in Exacerbations of Obstructive Lung Disease Respirology, March 26, 2013 Clinical Article
479 Sputum induction to aid the diagnosis of smear-negative or sputum-scarce TB in adults from a HIV-endemic setting European Respiratory Journal , March 26, 2013 Clinical Article
480 Ciliary dyskinesia is an early feature of respiratory syncytial virus infection European Respiratory Journal , March 26, 2013 Clinical Article
Using a murine mouse model of pneumonia, prolonged simvastatin therapy has a measureable effect on Streptococcus pneumoniae infection, but no effect on mortality. Mice were treated with simvastatin (1 mg/kg/d [low dose] or 10 mg/kg/d [high dose]) for 4 weeks, then infected with S. pneumoniae intrathecally. Mice treated with the high-dose regimen had less lung consolidation, decreased macrophage and neutrophil infiltration, decreased MCP-1, KC, and ICAM-1 production, and decreased bacterial titers in the blood 36 and 42 h post-infection. Despite these favorable physiologic effects, there was no effect on mortality compared to control mice treated with ampicillin 48 h post-infection.
Read the article summaryAs published in the European Journal of Internal Medicine, there were no mortalities in patients with community-acquired pneumonia (CAP) and low levels of D-dimer (< 500 ug/l). Of 147 patients in the study, D-dimer levels were elevated in those with severe CAP (2166 vs. 1630 ug/l), day 30-clinical failure (2228 vs. 1594 ug/l), early failure (2499 vs. 1669 ug/l), and non-survivors (3025 vs. 1680 ug/l). Importantly, D-dimer levels were not shown to be associated with clinical outcome based on multivariate analysis.
Read the article summaryAs published in the Journal of Infection, 114 of 981 (11.6%) of patients with pneumococcal pneumonia were bacteremic. Risk factors for bacteremia included immunosuppressants, age < 65 years, and diabetes mellitus. Patients with pneumococcal pneumonia and bacteria were at increased risk for mortality (28.6% vs. 8.5%). The combination of bacteremia, cerebrovascular disease, and septic shock had a strong association with mortality in patients with pneumococcal pneumonia.
Read the article summary1 Evidence-Based Review of the Management of Hepatic Hydrothorax Respiration, April 4, 2013 Review Article
2 Adjunctive therapies and immunomodulatory agents in the management of severe influenza Antiviral Research , April 12, 2013
3 Linezolid versus vancomycin or teicoplanin for nosocomial pneumonia: meta-analysis of randomised controlled trials European Journal of Clinical Microbiology & Infectious Diseases, April 10, 2013 Evidence Based Medicine
4 Effectiveness of treatment with high-frequency chest wall oscillation in patients with bronchiectasis BMC Pulmonary Medicine, April 5, 2013 Free full text
5 Prognostic value of plasma N-terminal pro B-type natriuretic peptide levels in pneumonia patients requiring intensive care unit admission Respirology, April 22, 2013
6 Prevention of Tuberculosis in Older Adults in the United States: Obstacles and Opportunities Clinical Infectious Diseases, April 9, 2013 Review Article
7 The Impact of Brief Corticosteroids on the Clinical Course of Primary Pulmonary Coccidioidomycosis Journal of Infection, April 9, 2013
8 Immunoglobulin G4-related lung disease: clinicoradiological and pathological features Respirology, November 14, 2012
9 Cytomegalovirus Pneumonia in Hematopoietic Stem Cell Recipients Journal of Intensive Care Medicine, February 8, 2013 Review Article
10 Waning Immunity to Pertussis Following 5 Doses of DTaP Pediatrics, April 3, 2013
11 Sweeper's lung disease: a cross-sectional study of an overlooked illness among sweepers of Pakistan International Journal of COPD, April 18, 2013 Free full text
12 β2-Agonist Therapy in Lung Disease American Journal of Respiratory and Critical Care Medicine, April 26, 2013 Review Article
13 Effect of Azithromycin Maintenance Treatment on Infectious Exacerbations Among Patients With Non–Cystic Fibrosis Bronchiectasis: The BAT Randomized Controlled Trial JAMA, March 27, 2013 Evidence Based Medicine
14 Effect of gastric versus post-pyloric feeding on the incidence of pneumonia in critically ill patients: Observations from traditional and Bayesian random-effects meta-analysis Clinical Nutrition, February 6, 2013 Evidence Based Medicine
15 Statins and the risk of interstitial lung disease: a cohort study Thorax, January 22, 2013
16 Factors associated with community-acquired pneumonia in hospitalised children and adolescents aged 6 months to 13 years old European Journal of Pediatrics, April 2, 2013 Review Article
17 Clinical outcomes of Pseudomonas aeruginosa pneumonia in intensive care unit patients Intensive Care Medicine, February 6, 2013
18 Amyloid-associated cystic lung disease in primary Sjogrens syndrome Respiratory Medicine, February 13, 2013
19 Incidence of pneumococcal infections among children under 15 years in southern Catalonia throughout the heptavalent conjugate vaccine era, 2002-2009 Infection, April 3, 2013
20 First Case of Pulmonary Disease Caused by a Strain of Mycobacterium avium Complex of Presumed Veterinary Origin in an Adult Human Patient Journal of Clinical Microbiology, April 8, 2013
Indexed Journals in Pulmonology: Chest, Thorax, American Journal of Respiratory and Critical Care Medicine more
Register now to view all the MDLinx contents (FREE)!
Login
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close